{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:49:09Z","timestamp":1761767349366,"version":"3.41.2"},"reference-count":28,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2324538","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T06:14:46Z","timestamp":1711001686000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China"],"prefix":"10.1080","volume":"20","author":[{"given":"Shaomin","family":"Chen","sequence":"first","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Ying","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yebin","family":"Yu","sequence":"additional","affiliation":[{"name":"Yangchun Center for Disease Control and Prevention","place":["Yangchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilian","family":"Huang","sequence":"additional","affiliation":[{"name":"Yangchun Center for Disease Control and Prevention","place":["Yangchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuhang","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Ou","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyi","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixiu","family":"Liu","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Shou","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Liao","sequence":"additional","affiliation":[{"name":"MSD Research and Development (China) Co. Ltd","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Tu","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Stek","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hartzel","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jikai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Institute of Biological Products and Materia Medica","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"World Health Organization. Rotavirus. [accessed 2023 Sep 19]. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccines-quality\/rotavirus."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.1960"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000799"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001327"},{"issue":"28","key":"e_1_3_6_6_1","first-page":"301","article-title":"Rotavirus vaccines: WHO position paper \u2013 July 2021","volume":"96","author":"World Health Organization","unstructured":"World Health Organization. Rotavirus vaccines: WHO position paper \u2013 July 2021. Wkly Epidemiol Rec. 96(28):301. [accessed 2023 Sep 19]. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/policies\/position-papers\/rotavirus.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.11.12847"},{"key":"e_1_3_6_8_1","unstructured":"National Medical Products Administration. List of approved domestic vaccine products in China. Rotavirus (Live) Vaccine Oral. [accessed 2023 Sep 19]. https:\/\/www.nmpa.gov.cn\/datasearch\/en\/search-info-en.html?nmpa=aWQ95Zu96I2v5YeG5a2XUzIwMDEwMDAyJml0ZW1JZD0yYzliYTM4MTc5ZDA4ZjRmMDE3OWQxM2NhNGY0MDA0ZQ==."},{"key":"e_1_3_6_9_1","unstructured":"RotaTeq. Local product circular. Shanghai: MSD China; 2018 [accessed 2024 Mar 4]. https:\/\/www.msdchina.com.cn\/wp-content\/uploads\/2023\/09\/%E4%B9%90%E5%84%BF%E5%BE%B7-%E8%AF%B4%E6%98%8E%E4%B9%A6-%E8%BF%9B%E5%8F%A3semi-%E7%AE%80%E7%89%88%EF%BC%88%E6%96%B9%E6%AD%A3%E9%BB%91%EF%BC%89-23.7.26-%E6%9B%B2%E7%BA%BF.pdf."},{"key":"e_1_3_6_10_1","unstructured":"National Medical Products Administration. List of approved domestic vaccine products in China. Reassortant Rotavirus Vaccine Live Oral Trivalent (Vero Cell). [accessed 2023 Sep 19]. https:\/\/www.nmpa.gov.cn\/datasearch\/search-info.html?nmpa=aWQ9YjFjOWVlMTQyOGJhMzkyZTFmMTdiN2ZkYjk0M2M1ZjQmaXRlbUlkPWZmODA4MDgxODNjYWQ3NTAwMTg0MDg4MWY4NDgxNzlm."},{"key":"e_1_3_6_11_1","unstructured":"RotaTeq [prescribing information]. Rahway (NJ): Merck Sharp & Dohme LLC; 2023 Apr. [accessed 2024 Mar 7]. https:\/\/www.fda.gov\/media\/75718\/download."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.081"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000254391.71103.e8"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181782780"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818c0161"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.02.018"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00437-10"},{"key":"e_1_3_6_18_1","unstructured":"World Health Organization. Position statement safety and pre-qualification of oral polio vaccine (OPV); 2006 May. [accessed 2023 Sep 19]. https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/09\/Position-statement_OPVsafety.pdf."},{"issue":"12","key":"e_1_3_6_19_1","first-page":"145","article-title":"Polio vaccines: WHO position paper \u2013 March 2016","volume":"91","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Polio vaccines: WHO position paper \u2013 March 2016. Wkly Epidemiol Rec. 2016;91(12):145. [accessed 2023 Sep 19]. https:\/\/www.who.int\/publications\/i\/item\/WHO-WER9112.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_20_1","unstructured":"World Health Organization. Polio eradication and endgame strategic plan 2013\u20132018. Geneva (Switzerland): World Health Organization; 2013. Polio Global Eradication Initiative. [accessed 2023 Sep 19]. https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf."},{"key":"e_1_3_6_21_1","first-page":"1","article-title":"Meeting of the strategic advisory group of experts on immunization, November 2012 - conclusions and recommendations","volume":"88","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Meeting of the strategic advisory group of experts on immunization, November 2012 - conclusions and recommendations. Wkly Epidemiol Rec. 2013;88:1. [accessed 2023 Sep 19]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/242011\/WER8801_1-16.PDF?sequence=1&isAllowed=y.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_22_1","unstructured":"World Health Organization. Polio eradication strategy 2022\u20132026: delivering on a promise. Geneva (Switzerland): World Health Organization; 2021. Polio Global Eradication Initiative. [accessed 2023 Sep 19]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/345967\/9789240031937-eng.pdf."},{"key":"e_1_3_6_23_1","unstructured":"World Health Organization. Poliomyelitis (polio) in China. [accessed 2023 Sep 19]. https:\/\/www.who.int\/china\/health-topics\/poliomyelitis-(polio)."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.46234\/ccdcw2021.270"},{"key":"e_1_3_6_25_1","unstructured":"World Health Organization. Recommendations to assure the quality safety and efficacy of poliomyelitis vaccines (inactivated) Annex 3 TRS No 1024. Amendment to Annex 3 of the WHO Technical Report Series No. 993; 2020 Nov 6. [accessed 2023 Sep 19]. https:\/\/www.who.int\/publications\/m\/item\/poliomyelitis-vaccines-annex-3-trs-no-1024."},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi033"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.091"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.006"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780040211"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2324538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:27:27Z","timestamp":1744651647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2324538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2324538"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2324538","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2324538"}}